267 related articles for article (PubMed ID: 9627331)
21. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
[TBL] [Abstract][Full Text] [Related]
22. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Oyama N; Miller TR; Dehdashti F; Siegel BA; Fischer KC; Michalski JM; Kibel AS; Andriole GL; Picus J; Welch MJ
J Nucl Med; 2003 Apr; 44(4):549-55. PubMed ID: 12679398
[TBL] [Abstract][Full Text] [Related]
23. [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Hautzel H; Müller-Mattheis V; Herzog H; Roden W; Coenen HH; Ackermann R; Müller-Gärtner HW; Krause BJ
Urologe A; 2002 Nov; 41(6):569-76. PubMed ID: 12524944
[TBL] [Abstract][Full Text] [Related]
24. Uptake rates of 18F-fluorodeoxyglucose and 11C-choline in lung cancer and pulmonary tuberculosis: a positron emission tomography study.
Hara T; Kosaka N; Suzuki T; Kudo K; Niino H
Chest; 2003 Sep; 124(3):893-901. PubMed ID: 12970014
[TBL] [Abstract][Full Text] [Related]
25. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
26. Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.
Hara T; Kosaka N; Kishi H
J Nucl Med; 2002 Feb; 43(2):187-99. PubMed ID: 11850483
[TBL] [Abstract][Full Text] [Related]
27. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
de Jong IJ; Pruim J; Elsinga PH; Jongen MM; Mensink HJ; Vaalburg W
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
[TBL] [Abstract][Full Text] [Related]
28. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
31. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Vees H; Buchegger F; Albrecht S; Khan H; Husarik D; Zaidi H; Soloviev D; Hany TF; Miralbell R
BJU Int; 2007 Jun; 99(6):1415-20. PubMed ID: 17428249
[TBL] [Abstract][Full Text] [Related]
32. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
Reske SN; Blumstein NM; Glatting G
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):9-17. PubMed ID: 17828534
[TBL] [Abstract][Full Text] [Related]
33. Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.
Ouyang Q; Duan Z; Lei J; Jiao G
Tumour Biol; 2016 Mar; 37(3):2999-3007. PubMed ID: 26415734
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Jadvar H
J Nucl Med; 2011 Jan; 52(1):81-9. PubMed ID: 21149473
[TBL] [Abstract][Full Text] [Related]
35. 11C-choline positron emission tomography in prostate cancer: primary staging and recurrent site staging.
Yoshida S; Nakagomi K; Goto S; Futatsubashi M; Torizuka T
Urol Int; 2005; 74(3):214-20. PubMed ID: 15812206
[TBL] [Abstract][Full Text] [Related]
36. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma.
Nanni C; Zamagni E; Cavo M; Rubello D; Tacchetti P; Pettinato C; Farsad M; Castellucci P; Ambrosini V; Montini GC; Al-Nahhas A; Franchi R; Fanti S
World J Surg Oncol; 2007 Jun; 5():68. PubMed ID: 17584499
[TBL] [Abstract][Full Text] [Related]
37. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
38. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
[TBL] [Abstract][Full Text] [Related]
39. 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
Nanni C; Schiavina R; Brunocilla E; Borghesi M; Ambrosini V; Zanoni L; Gentile G; Vagnoni V; Romagnoli D; Martorana G; Fanti S
Clin Genitourin Cancer; 2014 Apr; 12(2):106-10. PubMed ID: 24135632
[TBL] [Abstract][Full Text] [Related]
40. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging.
Ohtani T; Kurihara H; Ishiuchi S; Saito N; Oriuchi N; Inoue T; Sasaki T
Eur J Nucl Med; 2001 Nov; 28(11):1664-70. PubMed ID: 11702108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]